메뉴 건너뛰기




Volumn 31, Issue 52, 2013, Pages 6216-6224

Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques

Author keywords

AS01; CSV S,S; Immune response; Malaria; Plasmodium vivax; VMP001

Indexed keywords

3 O DESACYL 4 MONOPHOSPHORYL LIPID A; AS 01; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; MALARIA VACCINE; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIVAX MALARIA PROTEIN 1; VIVAX MALARIA PROTEIN 1 HEPATITS B SURFACE ANTIGEN FUSION PROTEIN; VMP 001;

EID: 84888427814     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.10.041     Document Type: Article
Times cited : (34)

References (43)
  • 1
    • 65949123374 scopus 로고    scopus 로고
    • Roll Back Malaria, Geneva
    • Roll Back Malaria Global malaria action plan 2008, Roll Back Malaria, Geneva, http://rbm.who.int/gmap/gmap.pdf.
    • (2008) Global malaria action plan
  • 2
    • 38949162591 scopus 로고    scopus 로고
    • Malaria eradication back on the table
    • Tanner M., de Savigny D. Malaria eradication back on the table. Bull World Health Organ 2008, 86(2):82. http://www.who.int/bulletin/volumes/86/2/07-050633/en/.
    • (2008) Bull World Health Organ , vol.86 , Issue.2 , pp. 82
    • Tanner, M.1    de Savigny, D.2
  • 4
    • 84856679687 scopus 로고    scopus 로고
    • Global malaria mortality between 1980 and 2010: a systematic analysis
    • Murray C.J.L., Rosenfeld L.C., Lim S.S., Andrews K.G., Foreman K.J., Haring D., et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379(9814):413-431.
    • (2012) Lancet , vol.379 , Issue.9814 , pp. 413-431
    • Murray, C.J.L.1    Rosenfeld, L.C.2    Lim, S.S.3    Andrews, K.G.4    Foreman, K.J.5    Haring, D.6
  • 6
    • 84888429299 scopus 로고    scopus 로고
    • World Health Organization. World malaria report.
    • World Health Organization. World malaria report. 2010. http://www.who.int/malaria/world_malaria_report_2010/worldmalariareport2010.pdf.
    • (2010)
  • 7
    • 76749083725 scopus 로고    scopus 로고
    • Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
    • Wells T.N.C., Burrows J.N., Baird J.K. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol 2010, 26(3):145-151.
    • (2010) Trends Parasitol , vol.26 , Issue.3 , pp. 145-151
    • Wells, T.N.C.1    Burrows, J.N.2    Baird, J.K.3
  • 8
    • 70849094363 scopus 로고    scopus 로고
    • Priorities in research and development of vaccines against Plasmodium vivax malaria
    • Brown G.V., Moorthy V.S., Reed Z., Mendis K., Arévalo-Herrera M., Alonso P. Priorities in research and development of vaccines against Plasmodium vivax malaria. Vaccine 2009, 27(52):7228-7235.
    • (2009) Vaccine , vol.27 , Issue.52 , pp. 7228-7235
    • Brown, G.V.1    Moorthy, V.S.2    Reed, Z.3    Mendis, K.4    Arévalo-Herrera, M.5    Alonso, P.6
  • 9
    • 84888433577 scopus 로고    scopus 로고
    • World Health Organization. Tables of malaria vaccine projects globally
    • World Health Organization. Tables of malaria vaccine projects globally. 2012. http://www.who.int/vaccine_research/links/Rainbow/en/index.html.
    • (2012)
  • 10
    • 0025974754 scopus 로고
    • Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites
    • Charoenvit Y., Mellouk S., Cole C., Bechara R., Leef M.F., Sedegah M., et al. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J Immunol 1991, 146(3):1020-1025.
    • (1991) J Immunol , vol.146 , Issue.3 , pp. 1020-1025
    • Charoenvit, Y.1    Mellouk, S.2    Cole, C.3    Bechara, R.4    Leef, M.F.5    Sedegah, M.6
  • 11
    • 66349098083 scopus 로고    scopus 로고
    • Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice
    • Kebaier C., Voza T., Vanderberg J. Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice. PLoS Pathog 2009, 5(4):e1000399.
    • (2009) PLoS Pathog , vol.5 , Issue.4
    • Kebaier, C.1    Voza, T.2    Vanderberg, J.3
  • 12
    • 0018887685 scopus 로고
    • Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection
    • Potocnjak P., Yoshida N., Nussenzweig R.S., Nussenzweig V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med 1980, 151(6):1504-1513.
    • (1980) J Exp Med , vol.151 , Issue.6 , pp. 1504-1513
    • Potocnjak, P.1    Yoshida, N.2    Nussenzweig, R.S.3    Nussenzweig, V.4
  • 13
    • 0025099759 scopus 로고
    • Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria
    • Tam J.P., Clavijo P., Lu Y.-A., Nussenzweig V., Nussenzweig R., Zavala F. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J Exp Med 1990, 171(1):299-306.
    • (1990) J Exp Med , vol.171 , Issue.1 , pp. 299-306
    • Tam, J.P.1    Clavijo, P.2    Lu, Y.-A.3    Nussenzweig, V.4    Nussenzweig, R.5    Zavala, F.6
  • 14
    • 0023622196 scopus 로고
    • Synthetic peptide vaccine confers protection against murine malaria
    • Zavala F., Tam J.P., Barr P.J., Romero P.J., Ley V., Nussenzweig R.S., et al. Synthetic peptide vaccine confers protection against murine malaria. J Exp Med 1987, 166(5):1591-1596.
    • (1987) J Exp Med , vol.166 , Issue.5 , pp. 1591-1596
    • Zavala, F.1    Tam, J.P.2    Barr, P.J.3    Romero, P.J.4    Ley, V.5    Nussenzweig, R.S.6
  • 15
    • 67650699591 scopus 로고    scopus 로고
    • Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection
    • Kester K.E., Cummings J.F., Ofori-Anyinam O., Ockenhouse C.F., Krzych U., Moris P., et al. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis 2009, 200(3):337-346.
    • (2009) J Infect Dis , vol.200 , Issue.3 , pp. 337-346
    • Kester, K.E.1    Cummings, J.F.2    Ofori-Anyinam, O.3    Ockenhouse, C.F.4    Krzych, U.5    Moris, P.6
  • 16
    • 0017345706 scopus 로고
    • Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man
    • McCarthy V.C., Clyde D.F. Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man. Exp Parasitol 1977, 41(1):167-171.
    • (1977) Exp Parasitol , vol.41 , Issue.1 , pp. 167-171
    • McCarthy, V.C.1    Clyde, D.F.2
  • 17
    • 0025777484 scopus 로고
    • Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence
    • Charoenvit Y., Collins W.E., Jones T.R., Millet P., Yuan L., Campbell G.H., et al. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science 1991, 251(4994):668-671.
    • (1991) Science , vol.251 , Issue.4994 , pp. 668-671
    • Charoenvit, Y.1    Collins, W.E.2    Jones, T.R.3    Millet, P.4    Yuan, L.5    Campbell, G.H.6
  • 18
    • 20244388248 scopus 로고    scopus 로고
    • Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin
    • Yang C., Collins W.E., Xiao L., Saekhou A.M., Reed R.C., Nelson C.O., et al. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin. Vaccine 1997, 15(4):377-386.
    • (1997) Vaccine , vol.15 , Issue.4 , pp. 377-386
    • Yang, C.1    Collins, W.E.2    Xiao, L.3    Saekhou, A.M.4    Reed, R.C.5    Nelson, C.O.6
  • 19
    • 33847754745 scopus 로고    scopus 로고
    • A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites
    • Yadava A., Sattabongkot J., Washington M.A., Ware L.A., Majam V., Zheng H., et al. A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites. Infect Immun 2007, 75(3):1177-1185.
    • (2007) Infect Immun , vol.75 , Issue.3 , pp. 1177-1185
    • Yadava, A.1    Sattabongkot, J.2    Washington, M.A.3    Ware, L.A.4    Majam, V.5    Zheng, H.6
  • 20
    • 59649124987 scopus 로고    scopus 로고
    • Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax
    • Bell B.A., Wood J.F., Bansal R., Ragab H., Cargo J., Washington M.A., et al. Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax. Vaccine 2009, 27(9):1448-1453.
    • (2009) Vaccine , vol.27 , Issue.9 , pp. 1448-1453
    • Bell, B.A.1    Wood, J.F.2    Bansal, R.3    Ragab, H.4    Cargo, J.5    Washington, M.A.6
  • 21
    • 84859818500 scopus 로고    scopus 로고
    • Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice
    • Lumsden J.M., Nurmukhambetova S., Klein J.H., Sattabongkot J., Bennett J.W., Bertholet S., et al. Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice. Vaccine 2012, 30(22):3311-3319.
    • (2012) Vaccine , vol.30 , Issue.22 , pp. 3311-3319
    • Lumsden, J.M.1    Nurmukhambetova, S.2    Klein, J.H.3    Sattabongkot, J.4    Bennett, J.W.5    Bertholet, S.6
  • 23
    • 84856686382 scopus 로고    scopus 로고
    • Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine
    • Moon J.J., Suh H., Polhemus M.E., Ockenhouse C.F., Yadava A., Irvine D.J. Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine. PLoS ONE 2012, 7(2):e31472.
    • (2012) PLoS ONE , vol.7 , Issue.2
    • Moon, J.J.1    Suh, H.2    Polhemus, M.E.3    Ockenhouse, C.F.4    Yadava, A.5    Irvine, D.J.6
  • 24
    • 80052316348 scopus 로고    scopus 로고
    • Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion
    • Lumsden J.M., Pichyangkul S., Srichairatanakul U., Yongvanitchit K., Limsalakpetch A., Nurmukhambetova S., et al. Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion. Infect Immun 2011, 79(9):3492-3500.
    • (2011) Infect Immun , vol.79 , Issue.9 , pp. 3492-3500
    • Lumsden, J.M.1    Pichyangkul, S.2    Srichairatanakul, U.3    Yongvanitchit, K.4    Limsalakpetch, A.5    Nurmukhambetova, S.6
  • 25
    • 33744791458 scopus 로고    scopus 로고
    • Particulate delivery systems for vaccines: what can we expect?
    • Bramwell V.W., Perrie Y. Particulate delivery systems for vaccines: what can we expect?. J Pharm Pharmacol 2006, 58(6):717-728.
    • (2006) J Pharm Pharmacol , vol.58 , Issue.6 , pp. 717-728
    • Bramwell, V.W.1    Perrie, Y.2
  • 26
    • 68949088019 scopus 로고    scopus 로고
    • The development of the RTS,S malaria vaccine candidate: challenges and lessons
    • Ballou W.R. The development of the RTS,S malaria vaccine candidate: challenges and lessons. Parasite Immunol 2009, 31(9):492-500.
    • (2009) Parasite Immunol , vol.31 , Issue.9 , pp. 492-500
    • Ballou, W.R.1
  • 27
    • 0024435569 scopus 로고
    • Simultaneous synthesis and assembly of various hepatitis B surface proteins in Saccharomyces cerevisiae
    • Jacobs E., Rutgers T., Voet P., Dewerchin M., Cabezon T., de Wilde M. Simultaneous synthesis and assembly of various hepatitis B surface proteins in Saccharomyces cerevisiae. Gene 1989, 80(2):279-291.
    • (1989) Gene , vol.80 , Issue.2 , pp. 279-291
    • Jacobs, E.1    Rutgers, T.2    Voet, P.3    Dewerchin, M.4    Cabezon, T.5    de Wilde, M.6
  • 28
    • 79955086319 scopus 로고    scopus 로고
    • Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
    • Garçon N., Van Mechelen M. Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems. Expert Rev Vaccines 2011, 10(4):471-486.
    • (2011) Expert Rev Vaccines , vol.10 , Issue.4 , pp. 471-486
    • Garçon, N.1    Van Mechelen, M.2
  • 29
    • 0003633755 scopus 로고    scopus 로고
    • The National Academy Press, Washington, DC, Institute for Laboratory Animal Research
    • Institute for Laboratory Animal Research Guide for the care and use of laboratory animals 1996, The National Academy Press, Washington, DC.
    • (1996) Guide for the care and use of laboratory animals
  • 30
    • 0022515486 scopus 로고
    • In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells
    • Hollingdale M.R., Collins W.E., Campbell C.C. In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells. Am J Trop Med Hyg 1986, 35(2):275-276.
    • (1986) Am J Trop Med Hyg , vol.35 , Issue.2 , pp. 275-276
    • Hollingdale, M.R.1    Collins, W.E.2    Campbell, C.C.3
  • 31
    • 33745887751 scopus 로고    scopus 로고
    • Induction of specific immune responses against the Plasmodium vivax liver-stage via in vitro activation by dendritic cells
    • Vichchathorn P., Jenwithisuk R., Leelaudomlipi S., Tungpradabkul S., Hongeng S., Cui L., et al. Induction of specific immune responses against the Plasmodium vivax liver-stage via in vitro activation by dendritic cells. Parasitol Int 2006, 55(3):187-193.
    • (2006) Parasitol Int , vol.55 , Issue.3 , pp. 187-193
    • Vichchathorn, P.1    Jenwithisuk, R.2    Leelaudomlipi, S.3    Tungpradabkul, S.4    Hongeng, S.5    Cui, L.6
  • 33
    • 28044446138 scopus 로고    scopus 로고
    • Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine
    • Herrera S., Bonelo A., Perlaza B.L., Fernández O.L., Victoria L., Lenis A.M., et al. Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine. Am J Trop Med Hyg 2005, 73(5 Suppl):3-9.
    • (2005) Am J Trop Med Hyg , vol.73 , Issue.5 SUPPL , pp. 3-9
    • Herrera, S.1    Bonelo, A.2    Perlaza, B.L.3    Fernández, O.L.4    Victoria, L.5    Lenis, A.M.6
  • 34
    • 79952468617 scopus 로고    scopus 로고
    • Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51
    • Herrera S., Fernández O.L., Vera O., Cárdenas W., Ramírez O., Palacios R., et al. Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51. Am J Trop Med Hyg 2011, 84(2 Suppl):12-20.
    • (2011) Am J Trop Med Hyg , vol.84 , Issue.2 SUPPL , pp. 12-20
    • Herrera, S.1    Fernández, O.L.2    Vera, O.3    Cárdenas, W.4    Ramírez, O.5    Palacios, R.6
  • 35
    • 84861541468 scopus 로고    scopus 로고
    • Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria
    • Yadava A., Nurmukhambetova S., Pichugin A.V., Lumsden J.M. Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria. J Infect Dis 2012, 205(9):1456-1463.
    • (2012) J Infect Dis , vol.205 , Issue.9 , pp. 1456-1463
    • Yadava, A.1    Nurmukhambetova, S.2    Pichugin, A.V.3    Lumsden, J.M.4
  • 36
    • 77951758823 scopus 로고    scopus 로고
    • Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites
    • Butler N.S., Schmidt N.W., Harty J.T. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J Immunol 2010, 184(5):2528-2538.
    • (2010) J Immunol , vol.184 , Issue.5 , pp. 2528-2538
    • Butler, N.S.1    Schmidt, N.W.2    Harty, J.T.3
  • 37
    • 79952379865 scopus 로고    scopus 로고
    • Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations
    • Depinay N., Franetich J.-F., Grüner A.C., Mauduit M., Chavatte J.-M., Luty A.J.F., et al. Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations. PLoS ONE 2011, 6(3):e17464.
    • (2011) PLoS ONE , vol.6 , Issue.3
    • Depinay, N.1    Franetich, J.-F.2    Grüner, A.C.3    Mauduit, M.4    Chavatte, J.-M.5    Luty, A.J.F.6
  • 38
    • 0034254649 scopus 로고    scopus 로고
    • The complexity of protective immunity against liver-stage malaria
    • Doolan D.L., Hoffman S.L. The complexity of protective immunity against liver-stage malaria. J Immunol 2000, 165(3):1453-1462.
    • (2000) J Immunol , vol.165 , Issue.3 , pp. 1453-1462
    • Doolan, D.L.1    Hoffman, S.L.2
  • 39
    • 0032745349 scopus 로고    scopus 로고
    • Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine
    • Lalvani A., Moris P., Voss G., Pathan A.A., Kester K.E., Brookes R., et al. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J Infect Dis 1999, 180(5):1656-1664.
    • (1999) J Infect Dis , vol.180 , Issue.5 , pp. 1656-1664
    • Lalvani, A.1    Moris, P.2    Voss, G.3    Pathan, A.A.4    Kester, K.E.5    Brookes, R.6
  • 41
    • 80053602298 scopus 로고    scopus 로고
    • Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria
    • Olotu A., Moris P., Mwacharo J., Vekemans J., Kimani D., Janssens M., et al. Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria. PLoS ONE 2011, 6(10):e25786.
    • (2011) PLoS ONE , vol.6 , Issue.10
    • Olotu, A.1    Moris, P.2    Mwacharo, J.3    Vekemans, J.4    Kimani, D.5    Janssens, M.6
  • 42
    • 11144353591 scopus 로고    scopus 로고
    • A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
    • Reece W.H.H., Pinder M., Gothard P.K., Milligan P., Bojang K., Doherty T., et al. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med 2004, 10(4):406-410.
    • (2004) Nat Med , vol.10 , Issue.4 , pp. 406-410
    • Reece, W.H.H.1    Pinder, M.2    Gothard, P.K.3    Milligan, P.4    Bojang, K.5    Doherty, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.